Consumers not benefiting from lowered drug prices: Policy expert

CNBC's "Power Lunch" discusses pharmaceutical company executives on the Capitol Hill and drug pricing with Bill Hoagland of BiPartisan Policy Center and David Maris of Wells Fargo.

» Subscribe to CNBC:

About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Connect with CNBC News Online
Get the latest news:
Find CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Google+:
Follow CNBC News on Instagram:

#CNBC

Power Lunch,CNBC,business news,finance stock,stock market,news channel,news station,breaking news,us news,world news,cable,cable news,finance news,money,money tips,financial news,stock market news,stocks,fda,fda approved,food and drug administration,drug prices,Pharmaceutical drug,Pharmaceuticals,Pharmaceutical industry,